Publication Information

{'id': 'https://openalex.org/W3175475609', 'doi': 'https://doi.org/10.1016/s1473-3099(21)00344-3', 'title': 'Global COVID-19 vaccine inequity', 'display_name': 'Global COVID-19 vaccine inequity', 'publication_year': 2021, 'publication_date': '2021-06-23', 'ids': {'openalex': 'https://openalex.org/W3175475609', 'doi': 'https://doi.org/10.1016/s1473-3099(21)00344-3', 'mag': '3175475609', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/34174236', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/8221728'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1016/s1473-3099(21)00344-3', 'pdf_url': 'http://www.thelancet.com/article/S1473309921003443/pdf', 'source': {'id': 'https://openalex.org/S23772524', 'display_name': 'The Lancet Infectious Diseases', 'issn_l': '1473-3099', 'issn': ['1473-3099', '1474-4457'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': 'other-oa', 'license_id': 'https://openalex.org/licenses/other-oa', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': True, 'oa_status': 'hybrid', 'oa_url': 'http://www.thelancet.com/article/S1473309921003443/pdf', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5067137018', 'display_name': 'Talha Burki', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': True, 'raw_author_name': 'Talha Burki', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': ['https://openalex.org/A5067137018'], 'corresponding_institution_ids': [], 'apc_list': {'value': 6300, 'currency': 'USD', 'value_usd': 6300, 'provenance': 'doaj'}, 'apc_paid': {'value': 6300, 'currency': 'USD', 'value_usd': 6300, 'provenance': 'doaj'}, 'fwci': 8.329, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 72, 'citation_normalized_percentile': {'value': 0.999904, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 98, 'max': 99}, 'biblio': {'volume': '21', 'issue': '7', 'first_page': '922', 'last_page': '923'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10833', 'display_name': 'Vaccine Coverage and Hesitancy', 'score': 0.9824, 'subfield': {'id': 'https://openalex.org/subfields/3306', 'display_name': 'Health'}, 'field': {'id': 'https://openalex.org/fields/33', 'display_name': 'Social Sciences'}, 'domain': {'id': 'https://openalex.org/domains/2', 'display_name': 'Social Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10833', 'display_name': 'Vaccine Coverage and Hesitancy', 'score': 0.9824, 'subfield': {'id': 'https://openalex.org/subfields/3306', 'display_name': 'Health'}, 'field': {'id': 'https://openalex.org/fields/33', 'display_name': 'Social Sciences'}, 'domain': {'id': 'https://openalex.org/domains/2', 'display_name': 'Social Sciences'}}, {'id': 'https://openalex.org/T11531', 'display_name': 'Healthcare Systems and Reforms', 'score': 0.9139, 'subfield': {'id': 'https://openalex.org/subfields/2003', 'display_name': 'Finance'}, 'field': {'id': 'https://openalex.org/fields/20', 'display_name': 'Economics, Econometrics and Finance'}, 'domain': {'id': 'https://openalex.org/domains/2', 'display_name': 'Social Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C3008058167', 'wikidata': 'https://www.wikidata.org/wiki/Q84263196', 'display_name': 'Coronavirus disease 2019 (COVID-19)', 'level': 4, 'score': 0.63681924}, {'id': 'https://openalex.org/C22070199', 'wikidata': 'https://www.wikidata.org/wiki/Q192995', 'display_name': 'Vaccination', 'level': 2, 'score': 0.5857675}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.5095375}, {'id': 'https://openalex.org/C2780801004', 'wikidata': 'https://www.wikidata.org/wiki/Q1415366', 'display_name': 'Immunization', 'level': 3, 'score': 0.4918301}, {'id': 'https://openalex.org/C3007834351', 'wikidata': 'https://www.wikidata.org/wiki/Q82069695', 'display_name': 'Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)', 'level': 5, 'score': 0.41456088}, {'id': 'https://openalex.org/C144133560', 'wikidata': 'https://www.wikidata.org/wiki/Q4830453', 'display_name': 'Business', 'level': 0, 'score': 0.3513876}, {'id': 'https://openalex.org/C17744445', 'wikidata': 'https://www.wikidata.org/wiki/Q36442', 'display_name': 'Political science', 'level': 0, 'score': 0.33072805}, {'id': 'https://openalex.org/C50522688', 'wikidata': 'https://www.wikidata.org/wiki/Q189833', 'display_name': 'Economic growth', 'level': 1, 'score': 0.32308447}, {'id': 'https://openalex.org/C159047783', 'wikidata': 'https://www.wikidata.org/wiki/Q7215', 'display_name': 'Virology', 'level': 1, 'score': 0.26380718}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.1583705}, {'id': 'https://openalex.org/C162324750', 'wikidata': 'https://www.wikidata.org/wiki/Q8134', 'display_name': 'Economics', 'level': 0, 'score': 0.12976605}, {'id': 'https://openalex.org/C524204448', 'wikidata': 'https://www.wikidata.org/wiki/Q788926', 'display_name': 'Infectious disease (medical specialty)', 'level': 3, 'score': 0.113518715}, {'id': 'https://openalex.org/C2779134260', 'wikidata': 'https://www.wikidata.org/wiki/Q12136', 'display_name': 'Disease', 'level': 2, 'score': 0.10859665}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C147483822', 'wikidata': 'https://www.wikidata.org/wiki/Q103537', 'display_name': 'Antigen', 'level': 2, 'score': 0.0}], 'mesh': [], 'locations_count': 2, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1016/s1473-3099(21)00344-3', 'pdf_url': 'http://www.thelancet.com/article/S1473309921003443/pdf', 'source': {'id': 'https://openalex.org/S23772524', 'display_name': 'The Lancet Infectious Diseases', 'issn_l': '1473-3099', 'issn': ['1473-3099', '1474-4457'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': 'other-oa', 'license_id': 'https://openalex.org/licenses/other-oa', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221728', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1016/s1473-3099(21)00344-3', 'pdf_url': 'http://www.thelancet.com/article/S1473309921003443/pdf', 'source': {'id': 'https://openalex.org/S23772524', 'display_name': 'The Lancet Infectious Diseases', 'issn_l': '1473-3099', 'issn': ['1473-3099', '1474-4457'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': 'other-oa', 'license_id': 'https://openalex.org/licenses/other-oa', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4292098121', 'https://openalex.org/W4224279380', 'https://openalex.org/W4210433452', 'https://openalex.org/W4206669628', 'https://openalex.org/W4206651655', 'https://openalex.org/W4206548596', 'https://openalex.org/W4205317059', 'https://openalex.org/W3176864053', 'https://openalex.org/W3084808338', 'https://openalex.org/W3036314732'], 'abstract_inverted_index': {'On': [0, 24, 248], 'May': [1, 25], '27,': [2, 26], 'the': [3, 28, 55, 93, 96, 117, 151, 174, 180, 187, 193, 211, 214, 220, 231, 235, 257, 305, 313, 323, 336, 345, 383, 428, 442, 445, 449, 459, 493, 510, 515, 536, 554, 558, 561, 564, 616, 622, 649, 678, 681, 705, 713, 719, 726, 739, 752, 786, 808, 814, 830, 838, 906, 920, 938, 943, 1018, 1052, 1057, 1083, 1090, 1115, 1119, 1124, 1127, 1140, 1154, 1157, 1202], 'Strategic': [4, 30], 'Advisory': [5, 31], 'Group': [6, 32], 'of': [7, 33, 95, 132, 153, 160, 167, 186, 199, 204, 213, 222, 278, 304, 322, 331, 361, 374, 444, 451, 488, 573, 619, 680, 721, 746, 788, 813, 845, 946, 955, 991, 996, 1041, 1059, 1103, 1122, 1126, 1139, 1174], 'Experts': [8, 34], 'on': [9, 35, 219, 816, 828, 905, 1029], 'Immunization': [10, 36], 'met': [11], 'virtually': [12], 'to': [13, 39, 106, 172, 191, 207, 256, 261, 300, 371, 390, 405, 431, 440, 458, 481, 508, 533, 598, 614, 629, 671, 715, 729, 754, 777, 810, 826, 837, 875, 933, 948, 984, 1011, 1051, 1056, 1082, 1098, 1192, 1200], 'discuss': [14, 40], 'global': [15], 'COVID-19': [16, 41, 118, 133, 333, 362, 526], 'vaccine': [17, 111, 176, 188, 254, 394, 489, 599, 633, 846, 879, 926, 964, 1047, 1064, 1164, 1175], 'distribution': [18], 'and': [19, 51, 59, 115, 177, 270, 347, 364, 385, 408, 501, 557, 591, 743, 782, 802, 908, 957, 1156, 1178, 1187], 'inequity.': [20], 'Talha': [21], 'Burki': [22], 'reports.': [23], '2021,': [27, 512], 'WHO': [29, 251, 285, 500], '(SAGE)': [37], 'convened': [38], 'vaccines.': [42, 527], '15': [43], 'vaccines': [44, 134, 363, 912, 947, 1128], 'are': [45, 54, 243, 272, 282, 397, 403, 490, 546, 550, 913, 929, 1022, 1094, 1130, 1190], 'currently': [46, 998], 'in': [47, 189, 196, 276, 294, 312, 472, 498, 547, 585, 883, 930, 971, 988, 999, 1039, 1132], 'use': [48], '(the': [49], 'Oxford-AstraZeneca': [50, 175], 'Pfizer-BioNTech': [52, 97], 'products': [53, 1025], 'most': [56], 'widely': [57], 'used),': [58], '1·9': [60], 'billion': [61, 359, 486, 843], 'doses': [62, 81, 131, 290, 360, 487, 844], 'had': [63, 178, 259, 865], 'been': [64, 292, 1147], 'administered': [65, 77, 293, 1142], 'by': [66, 150, 210, 344, 514, 563, 1149], 'June': [67, 154, 249], '7,': [68], '2021.': [69, 661], '“Inequity': [70], 'is': [71, 136, 170, 338, 422, 427, 531, 582, 854, 873, 880, 1108, 1118, 1171, 1180], 'decreasing,': [72], 'but': [73, 135, 694, 867, 885], 'high-income': [74, 354, 1196], 'countries': [75, 355, 402, 462, 545, 586, 1135, 1189, 1197], 'have': [76, 157, 291, 366, 387, 463, 833, 1159, 1199], '69': [78], 'times': [79], 'more': [80, 127, 316, 407, 409, 542, 1163], 'per': [82], 'inhabitant': [83], 'than': [84, 128, 317, 378, 543, 863, 1165], 'low-income': [85, 495, 1186], 'countries”,': [86], 'stated': [87], 'SAGE.': [88], 'The': [89, 164, 201, 417, 793, 993, 1144, 1152], 'meeting': [90], 'heard': [91], 'from': [92, 116, 434, 712, 806, 1013, 1089], 'manufacturers': [94, 749], 'vaccine,': [98], 'who': [99, 1015], 'confirmed': [100], 'that': [101, 149, 253, 287, 351, 353, 401, 425, 518, 570, 580, 593, 604, 648, 709, 725, 820, 888, 1020, 1071, 1129], 'they': [102, 832, 1166], 'would': [103, 607, 657, 666, 684, 710, 733, 821, 894, 941, 975], 'be': [104, 238, 471, 576, 596, 658, 685, 716, 734, 768, 849, 895, 976, 981, 1038, 1080, 1193], 'able': [105], 'produce': [107, 173, 630], 'a': [108, 145, 158, 262, 301, 308, 332, 435, 473, 529, 605, 651, 817, 861, 869, 892, 896, 931, 972, 1009, 1044, 1063, 1069, 1075, 1100, 1172], 'new': [109, 758], 'variant': [110], 'within': [112, 224], '100': [113, 544, 925], 'days,': [114], 'Vaccines': [119], 'Global': [120, 641], 'Access': [121], '(COVAX)': [122], 'Facility,': [123, 182], 'which': [124, 169, 298, 676, 1026], 'has': [125, 143, 183, 626, 900, 1086, 1146], 'shipped': [126], '80': [129], 'million': [130, 162, 289, 319, 393, 859, 890], 'now': [137, 901], 'facing': [138], 'severe': [139, 917], 'supply': [140], 'constrictions.': [141], 'COVAX': [142, 181, 340, 1179], 'issued': [144, 902], 'statement': [146], 'pointing': [147], 'out': [148, 647, 1176], 'end': [152, 212], 'it': [155, 426, 519, 567, 635, 772, 864, 1078], 'will': [156, 217, 470, 575, 847, 1198], 'shortfall': [159], '190': [161], 'doses.': [163, 395, 1143], 'Serum': [165, 202, 744], 'Institute': [166, 203, 745], 'India,': [168], 'licensed': [171], 'supplied': [179], 'suspended': [184], 'exports': [185, 209], 'order': [190], 'combat': [192], 'huge': [194], 'surge': [195], 'domestic': [197], 'cases': [198, 277], 'COVID-19.': [200, 279], 'India': [205], 'hopes': [206], 'resume': [208], 'year.': [215, 852], 'Much': [216], 'depend': [218], 'pace': [221], 'vaccination': [223], 'India.': [225, 747], '“If': [226, 454], 'we': [227, 455, 469, 799, 940, 979, 1021, 1031, 1110], 'do': [228, 1002], 'not': [229, 695, 702, 1003, 1073, 1191], 'address': [230], 'current,': [232], 'urgent': [233], 'shortfall,': [234], 'consequences': [236], 'could': [237, 356, 594, 653, 689, 701, 763, 1037, 1079], 'catastrophic”,': [239], 'asserted': [240], 'COVAX.': [241, 499], 'There': [242], 'particular': [244], 'concerns': [245], 'for': [246, 492, 525, 640, 1017, 1024, 1137], 'Africa.': [247], '3,': [250], 'warned': [252], 'shipments': [255], 'continent': [258], 'ground': [260], 'near': [263], 'halt.': [264], 'Several': [265], 'countries,': [266], 'including': [267, 553], 'Angola,': [268], 'Namibia,': [269], 'Uganda,': [271], 'seeing': [273, 398], 'sharp': [274], 'rises': [275], 'Vaccine': [280], 'supplies': [281], 'running': [283, 855], 'low.': [284], 'noted': [286], '31·4': [288], '50': [295], 'African': [296], 'nations,': [297], 'equates': [299], 'mere': [302], '2%': [303], 'population': [306, 376], 'receiving': [307, 1181], 'single': [309, 973], 'dose.': [310], 'Yet': [311], 'UK': [314], 'alone,': [315], '40': [318], 'people—over': [320], '70%': [321], 'adult': [324], 'population—have': [325], 'received': [326], 'at': [327, 483, 535, 856], 'least': [328, 484], 'one': [329], 'dose': [330], 'vaccine.': [334], 'Globally,': [335], 'average': [337], '24%.': [339], 'highlighted': [341], 'an': [342, 423], 'analysis': [343], 'Bill': [346], 'Melinda': [348], 'Gates': [349], 'Foundation': [350], 'concluded': [352], 'share': [357], '1': [358], 'still': [365, 868], 'enough': [367], 'product': [368, 1070], 'left': [369, 1194], 'over': [370], 'vaccinate': [372], '80%': [373], 'their': [375, 465, 986], 'older': [377], '12': [379], 'years.': [380], 'Thus': [381], 'far,': [382], 'USA': [384, 565, 1158], 'Europe': [386], 'collectively': [388], 'pledged': [389], 'donate': [391], '180': [392], '“We': [396, 700, 766, 928, 1007, 1093], 'strong': [399], 'signs': [400], 'going': [404], 'release': [406], 'doses”,': [410], 'Margaret': [411], 'Harris': [412], '(WHO,': [413], 'Geneva,': [414], 'Switzerland)': [415], 'told': [416, 792], 'Lancet': [418, 794], 'Infectious': [419, 795], 'Diseases.': [420, 796], '“There': [421, 1170], 'understanding': [424], 'right': [429], 'thing': [430], 'do,': [432], 'even': [433], 'practical': [436], 'perspective,': [437], 'so': [438], 'as': [439, 588, 631, 634, 738, 773, 775, 1062], 'minimise': [441], 'risk': [443], 'variants.”': [446], 'She': [447], 'stressed': [448], 'importance': [450], 'acting': [452], 'quickly.': [453], 'can': [456, 800, 1167], 'get': [457], 'stage': [460], 'where': [461], 'vaccinated': [464], 'priority': [466], 'groups': [467], 'then': [468, 667], 'much': [474, 613, 632, 878], 'better': [475], 'place”,': [476], 'said': [477, 950, 1105, 1183], 'Harris.': [478, 1184], 'For': [479], 'this': [480, 696, 851], 'happen,': [482], '1·3': [485], 'needed': [491], '92': [494], 'economies': [496], 'participating': [497], 'Médecins': [502], 'Sans': [503], 'Frontières': [504], 'were': [505], 'among': [506], 'those': [507, 989, 1014], 'welcome': [509], 'May,': [511], 'announcement': [513, 562], 'US': [516], 'Government': [517], 'backed': [520], 'waiving': [521], 'intellectual': [522], 'property': [523], 'protections': [524], 'Such': [528], 'waiver': [530, 574, 606, 652, 688, 714], 'subject': [532], 'negotiations': [534], 'World': [537], 'Trade': [538], 'Organization.': [539], 'But': [540], 'although': [541], 'support,': [548], 'there': [549, 581, 1117], 'powerful': [551], 'opponents,': [552], 'EU,': [555, 1153], 'Japan,': [556], 'UK.': [559], 'Still,': [560], 'makes': [566], 'far': [568, 1162], 'likelier': [569], 'some': [571], 'kind': [572], 'introduced.': [577], 'Proponents': [578], 'argue': [579], 'unused': [583], 'capacity': [584, 665], 'such': [587, 737, 1061], 'Bangladesh,': [589], 'Canada,': [590], 'Israel': [592], 'easily': [595], 'turned': [597], 'production.': [600, 1133], 'Those': [601], 'opposed': [602], 'counter': [603], 'discourage': [608], 'future': [609], 'innovation': [610], 'without': [611], 'doing': [612, 1095, 1112], 'solve': [615], 'pressing': [617], 'problem': [618, 1121], 'supply—after': [620], 'all,': [621], 'pharmaceutical': [623], 'industry': [624], 'already': [625, 834, 1032, 1131], 'every': [627], 'incentive': [628], 'can.': [636], 'Prashant': [637], 'Yadav': [638, 723, 791, 886], '(Center': [639], 'Development,': [642], 'Washington,': [643], 'DC,': [644], 'USA)': [645], 'points': [646], 'earliest': [650], 'come': [654], 'into': [655], 'force': [656], 'around': [659, 857, 924], 'October,': [660], 'Countries': [662], 'with': [663, 1048, 1065], 'spare': [664, 751], 'require': [668, 1074], 'several': [669], 'months': [670], 'set': [672, 756, 945], 'up': [673, 757], 'production,': [674], 'during': [675], 'time': [677, 1109], 'co-operation': [679], 'developing': [682], 'company': [683], 'vital.': [686], '“A': [687, 962], 'potentially': [690], 'help': [691, 755, 783], 'increase': [692], 'supply,': [693], 'year”,': [697], 'explained': [698], 'Yadav.': [699, 1035, 1106], 'realistically': [703], 'expect': [704], 'first': [706], 'commercial': [707, 789], 'batches': [708], 'result': [711], 'available': [717], 'until': [718], 'summer': [720], '2022.”': [722], 'believes': [724], 'quickest': [727], 'way': [728], 'achieve': [730], 'greater': [731, 1066], 'output': [732], 'voluntary': [735], 'licensing,': [736], 'arrangement': [740], 'between': [741], 'AstraZeneca': [742, 853], 'If': [748, 1185], 'cannot': [750], 'staff': [753], 'sites,': [759], 'perhaps': [760], 'external': [761], 'organisations': [762], 'step': [764], 'in.': [765], 'should': [767, 980], 'thinking': [769], 'about': [770, 937], 'making': [771], 'easy': [774], 'possible': [776], 'establish': [778], 'secondary': [779], 'manufacturing': [780, 804], 'sites': [781], 'companies': [784], 'navigate': [785], 'complexities': [787], 'partnerships”,': [790], '“So': [797], 'if': [798], 'recruit': [801], 'pay': [803, 1016], 'experts': [805], 'outside': [807], 'companies,': [809], 'take': [811], 'care': [812], 'work': [815], 'contract': [818], 'basis,': [819], 'leave': [822], 'internal': [823], 'management': [824], 'free': [825], 'concentrate': [827], 'fulfilling': [829], 'contracts': [831], 'signed.”': [835], 'According': [836], 'International': [839], 'Monetary': [840], 'Fund,': [841], '6': [842], 'probably': [848], 'produced': [850], '150': [858], 'units': [860, 891], 'month—less': [862], 'anticipated': [866], 'hefty': [870], 'amount.': [871], 'It': [872], 'hard': [874], 'know': [876], 'how': [877], 'being': [881], 'manufactured': [882], 'China,': [884], 'reckons': [887], '300': [889], 'month': [893], 'reasonable': [897], 'estimate.': [898], 'SAGE': [899], 'interim': [903], 'recommendations': [904], 'Sinopharm': [907], 'Sinovac': [909], 'products.': [910], 'Both': [911], 'highly': [914], 'effective': [915], 'against': [916], 'disease.': [918], 'In': [919, 1114], 'clinical': [921, 1000], 'pipeline': [922], 'lie': [923], 'candidates.': [927], 'position': [932], 'start': [934], 'getting': [935], 'specific': [936], 'characteristics': [939], 'like': [942], 'next': [944], 'have”,': [949, 1033], 'Olivier': [951], 'Wouters': [952], '(London': [953], 'School': [954], 'Economics': [956], 'Political': [958], 'Science,': [959], 'London,': [960], 'UK).': [961], 'nasal': [963], 'or': [965, 1068], 'something': [966], 'orally': [967], 'administered,': [968], 'ideally': [969], 'given': [970], 'dose,': [974], 'tremendously': [977], 'useful;': [978], 'encouraging': [982], 'developers': [983], 'focus': [985], 'attention': [987], 'sorts': [990], 'directions.”': [992], 'vast': [994], 'majority': [995], 'candidates': [997], 'development': [1001], 'fulfil': [1004], 'these': [1005], 'conditions.': [1006], 'need': [1008], 'signal': [1010], 'developers,': [1012], 'vaccines,': [1019], 'looking': [1023], 'radically': [1027], 'improve': [1028], 'what': [1030], 'argues': [1034], 'This': [1036], 'terms': [1040], 'properties—for': [1042], 'example,': [1043], 'viral': [1045], 'vector': [1046], 'similar': [1049], 'efficacy': [1050], 'mRNA': [1053], 'vaccines—or': [1054], 'related': [1055], 'ease': [1058], 'delivery,': [1060], 'thermostability': [1067], 'does': [1072], 'syringe.': [1076], 'Or': [1077], 'down': [1081], 'target—perhaps': [1084], 'SARS-CoV-2': [1085], 'vulnerabilities': [1087], 'aside': [1088], 'spike': [1091], 'protein.': [1092], 'very': [1096], 'little': [1097], 'incentivise': [1099], 'diverse': [1101], 'range': [1102], 'products”,': [1104], '“It': [1107], 'started': [1111], 'so.”': [1113], 'short-term,': [1116], 'sizeable': [1120], 'increasing': [1123], 'availability': [1125], 'Ten': [1134], 'account': [1136], '77%': [1138], 'globally': [1141], 'market': [1145], 'cornered': [1148], 'rich': [1150], 'nations.': [1151], 'UK,': [1155], 'all': [1160], 'purchased': [1161], 'possibly': [1168], 'use.': [1169], 'lake': [1173], 'there,': [1177], 'drops”,': [1182], 'middle-income': [1188], 'behind,': [1195], 'open': [1201], 'floodgates.': [1203]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W3175475609', 'counts_by_year': [{'year': 2024, 'cited_by_count': 10}, {'year': 2023, 'cited_by_count': 21}, {'year': 2022, 'cited_by_count': 31}, {'year': 2021, 'cited_by_count': 10}], 'updated_date': '2025-01-10T00:25:02.853154', 'created_date': '2021-07-05'}